Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study

L. Guimaraes de Sousa; S. Liu; P. Bhosale; M. Altan; W. Darbonne; K. Schulze; S. Dervin; C. Yun; A. Mahvash; A. Verma; A. Futreal; S. Gite; E. Parra Cuentas; W. C. Cho; I. Wistuba; J. C. Yao; S. E. Woodman; D. M. Halperin; R. Ferrarotto

doi:10.1016/j.oraloncology.2024.106747

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study

L. Guimaraes de Sousa, S. Liu, P. Bhosale, M. Altan, W. Darbonne, K. Schulze, S. Dervin, C. Yun, A. Mahvash, A. Verma, A. Futreal, S. Gite, E. Parra Cuentas, W. C. Cho, I. Wistuba, J. C. Yao, S. E. Woodman, D. M. Halperin, R. Ferrarotto

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	106747
Journal	Oral Oncology
Volume	151
DOIs	https://doi.org/10.1016/j.oraloncology.2024.106747
State	Published - Apr 2024

ASJC Scopus subject areas

Oral Surgery
Oncology
Cancer Research

Access to Document

10.1016/j.oraloncology.2024.106747

Cite this

de Sousa, L. G., Liu, S., Bhosale, P., Altan, M., Darbonne, W., Schulze, K., Dervin, S., Yun, C., Mahvash, A., Verma, A., Futreal, A., Gite, S., Cuentas, E. P., Cho, W. C., Wistuba, I., Yao, J. C., Woodman, S. E., Halperin, D. M., & Ferrarotto, R. (2024). Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study. Oral Oncology, 151, Article 106747. https://doi.org/10.1016/j.oraloncology.2024.106747

de Sousa, LG , Liu, S , Bhosale, P , Altan, M, Darbonne, W, Schulze, K, Dervin, S, Yun, C, Mahvash, A, Verma, A, Futreal, A, Gite, S, Cuentas, EP , Cho, WC , Wistuba, I , Yao, JC , Woodman, SE , Halperin, DM & Ferrarotto, R 2024, 'Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study', Oral Oncology, vol. 151, 106747. https://doi.org/10.1016/j.oraloncology.2024.106747

@article{e95787b90b9b45c2aa65951bfe7191d8,

title = "Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study",

author = "{de Sousa}, {L. Guimaraes} and S. Liu and P. Bhosale and M. Altan and W. Darbonne and K. Schulze and S. Dervin and C. Yun and A. Mahvash and A. Verma and A. Futreal and S. Gite and Cuentas, {E. Parra} and Cho, {W. C.} and I. Wistuba and Yao, {J. C.} and Woodman, {S. E.} and Halperin, {D. M.} and R. Ferrarotto",

year = "2024",

month = apr,

doi = "10.1016/j.oraloncology.2024.106747",

language = "English (US)",

volume = "151",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma

T2 - A prospective study

AU - de Sousa, L. Guimaraes

AU - Liu, S.

AU - Bhosale, P.

AU - Altan, M.

AU - Darbonne, W.

AU - Schulze, K.

AU - Dervin, S.

AU - Yun, C.

AU - Mahvash, A.

AU - Verma, A.

AU - Futreal, A.

AU - Gite, S.

AU - Cuentas, E. Parra

AU - Cho, W. C.

AU - Wistuba, I.

AU - Yao, J. C.

AU - Woodman, S. E.

AU - Halperin, D. M.

AU - Ferrarotto, R.

PY - 2024/4

Y1 - 2024/4

UR - http://www.scopus.com/inward/record.url?scp=85186985307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85186985307&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2024.106747

DO - 10.1016/j.oraloncology.2024.106747

M3 - Letter

C2 - 38460288

AN - SCOPUS:85186985307

SN - 1368-8375

VL - 151

JO - Oral Oncology

JF - Oral Oncology

M1 - 106747

ER -

Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this